logo

For the Inventor, By the Inventor

Newton, MA, United States of America

Mu-En Lee

USPTO Granted Patents = 17

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 113(Granted Patents)


Company Filing History:

goldMedal16 out of 2,963 
 
Harvard College
 patents
silverMedal1 out of 12 
 
Harvard Corporation
 patents

Years Active: 1996-2006

Loading Chart...
17 patents (USPTO):Explore Patents
1. 7094878 - Aortic carboxypeptidase-like polypeptide (2006-08-22),
2. 6514935 - Methods of treating hypertension (2003-02-04),
3. 6468766 - Aortic carboxypeptidase-like polypeptide (2002-10-22),
4. 6399753 - Striated-specific muscle cell polypetides (2002-06-04),
5. 6395548 - Methods of modulating of angiogenesis (2002-05-28),
6. 6350592 - Aortic-specific enhancer sequence and uses thereof (2002-02-26),
7. 6258557 - Smooth muscle cell LIM promoter (2001-07-10),
8. 6136953 - Smooth muscle cell LIM protein (2000-10-24),
9. 6077933 - Repressor Kruppel-like factor (2000-06-20),
10. 5928941 - Repressor kruppel-like factor (1999-07-27),
11. 5888982 - Regulation of vascular smooth muscle cell heme oxygenase-1 (1999-03-30),
12. 5888765 - Endothelial-cell specific promoter (1999-03-30),
13. 5846773 - Single gene encoding aortic-specific and striated-specific muscle cell (1998-12-08),
14. 5786171 - Aortic preferentially expressed gene and uses thereof (1998-07-28),
15. 5767262 - Smooth muscle cell LIM protein (1998-06-16),

Title: Innovations and Contributions of Inventor Mu-En Lee

Introduction

Mu-En Lee is a prominent inventor based in Newton, MA, known for her significant contributions to the field of biomedical research. With a total of 17 patents to her name, she has made remarkable advancements in understanding and treating various health conditions.

Latest Patents

Among her latest patents is the invention of an aortic carboxypeptidase-like polypeptide (ACLP). This invention includes DNA encoding ACLP and methods for detecting genetic alterations associated with abdominal wall defects. Another notable patent involves methods of treating hypertension, which features a method of inhibiting hypertension in a mammal by administering a compound that reduces the expression or activity of SmLIM.

Career Highlights

Mu-En Lee has had a distinguished career, working with prestigious institutions such as Harvard College and Harvard Corporation. Her work has been instrumental in advancing medical research and developing innovative treatments.

Collaborations

Throughout her career, Mu-En has collaborated with esteemed colleagues, including Shaw-Fang Yet and Edgar Haber. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Mu-En Lee's innovative work and dedication to biomedical research have led to significant advancements in health treatments. Her contributions continue to impact the field positively, showcasing her role as a leading inventor.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…